Navigation Links
OROS(R) Methylphenidate in Adults with ADHD: New Insights
Date:5/7/2008

ome. Abuse of methylphenidate may lead to dependence. Tell your health care professional if your child has had problems with alcohol or drugs, has had depression, abnormal thoughts or visions, bipolar disorder, seizures, high blood pressure or has had any heart problems or defects. If your child develops abnormal thinking or hallucinations, abnormal, extreme moods and/or excessive activity, or if aggressive behavior or hostility develops or worsens while taking OROS(R) MPH, consult your health care professional. The most common adverse events reported in children receiving up to 54 mg were headache, upper respiratory tract infection and abdominal pain. The most common adverse events reported by adolescents receiving up to 72 mg were headache, accidental injury and insomnia.

Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) is part of Johnson & Johnson, the world's most broadly based producer of healthcare products. J&JPRD is headquartered in Raritan, NJ, and has facilities throughout Asia, Europe and the United States. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas to address unmet medical needs worldwide.

McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is committed to meeting the needs of pediatric medicine through the development of therapies specifically formulated for children. McNeil Pediatrics(TM) markets OROS(R) methylphenidate HCL for treatment of children and adolescents with ADHD in the US. McNeil Pediatrics(TM) is continuing to explore other new therapies to meet the special needs of children and the pediatric community. Visit http://www.mcneilpediatrics.net/ for more information.

OROS(R) is a registered trademark of ALZA Corporation.

1: Kessler RC et al, Journal of American Occupational Environmental

Medicine 2005

2: Kessler RC, Adler L, Barkley R, et
'/>"/>

SOURCE McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Commonly used medications associated with impaired physical function in older adults
2. Pennsylvania Governor Rendell Says Enactment of PA ABC Would Help More Than 8,000 Uninsured Adults in Schuylkill County
3. New Book Helps Older Adults Manage Chronic Pain
4. Los Angeles Jewish Home Unveils Auerbach Behavioral Health Center Filling Community Void for Adults Over 55
5. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
6. Social form of bullying linked to depression, anxiety in adults
7. Rat study suggests why teens get hooked on cocaine more easily than adults
8. Grocery Manufacturers Association: Canadian Risk Assessment Reaffirms Safety of Bisphenol A (BPA) for Adults and Children
9. Todays Working Adults Face Long Term Care Double Whammy, Says Denise Gott, Spokesperson for LTC Financial Partners, LLC
10. Youth and Adults Throughout Illinois Urge Governor Blagojevich and Congress: Invest Our Tax Dollars Wisely
11. AUDIO from Medialink and Apple Products Research and Education Council: New Research -- Adults Who Eat Apples, Apple Juice Have Healthier Diets and Lower Risk for Metabolic Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ith new cells regained sexual function, study says... -- Researchers were able to restore sexual functi...penile tissue in the lab and implanting it, a new ...a ways off, researchers say the technique could on... in men. , "We were able to show the tissue was...
(Date:11/9/2009)...na, Nov. 9 /PRNewswire-FirstCall/ - Hard To Treat ...d today that Novartis, a US$41 billion internation...n HTDS, H1N1 Vaccine partner, Zhejiang Tianyuan Bi...vartis of Switzerland will begin a five-year, $1 b... will dramatically increase its investment in its ...
(Date:11/9/2009)... Tomorrow may be too late when it comes to p...ding to TOPS Club, Inc. (Take Off Pounds Sensibly)... , (Vocus) November 9, 200...venting or improving a diabetes condition, accordi...the nonprofit weight-loss support organization., ,...
(Date:11/9/2009)... New study highlights positive influence of ... Rosemont, IL (Vocus) November 9, 2009...th decreases. Recent research has highlighted the ...help prevent these issues. However, a new study pu...Health: A Multidisciplinary Approach reveals that...
(Date:11/9/2009)... Calif., Nov. 9 Actress Mariska Ha... philosophy on Saturday to raise awareness abou...throughout California by building healing and well...ts were created to give one to each of the estimat...Angeles County,s domestic violence shelters. ,,...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3
... six months old is not advisable as it may lead to...uld rather breastfeed them exclusively, scientists...oided for the first six months, and certain items ...ACAAI), reported online edition of health magazine...
...scarriage, for a couple, appears to rise along wit... mother// according to a recent report by research...They conducted their study on nearly 14,000 women ...icipants who delivered a baby. The researchers fou...
...ia have suggested that cross-immunity created in r...in protect against infection // by related seroty...engue epidemics. This finding would help understa...he dominant serotype," said lead author Helen Wear...
... disease caused by filarial worm Onchocerca volvul...s craw craw is an endemic disease in Bioko Island,... black flies causes weakening in affected individu...he environmental conditions and altitude of Bioko ...
...iversity of Florida, Gainesville, mice based exper...enes to treat hereditary diseases of the heart.// ... in mice affected with muscular dystrophy that dam...soon as early next year for patients with Pompe di...
... of north India, encephalitis has once again struc...e virus has already claimed the lives of 36 childr...ies claim the currently spreading virus was not th... any of the 223 cases that have been reported sinc...
Other Medicine News:Health News:Risk of Miscarriage Rises with Father’s Ag 2Health News:Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity 2Health News:Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity 3Health News:River Blindness Incidence Reduced With Effective Treatment 2Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 2Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 3Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 4Health News:36 Children Die of Encephalitis in Uttar Pradesh 2
(Date:11/7/2009)...ACH, Fla., Nov. 7 Most patients wi...toms that signal an oncoming HAE attack giving the...d decrease the morbidity associated with that atta...t the 2009 American College of Allergy, Asthma &am...ition of symptoms such as fatigue and nausea, whic...
(Date:11/6/2009)...N.C., Nov. 6 Oxygen Biot... announced that a previously approved reverse spli...t of trading on Monday, Nov. 9, 2009 on a 1-for-15.... shares will trade under the new symbol OXBT. The...0 9, when the split becomes effective. ,, "This...
(Date:11/6/2009)..., FORT WASHINGTON, Pa., Nov. 6 In ...ation (FDA), McNeil Consumer Healthcare, Division ...all of a limited number of product lots of TYLENOL...th the distinctive red EZ-OPEN CAP. McNeil is init...istic smell or taste associated with these lots th...
Breaking Medicine Technology:Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Craneware Announces Fiscal Year End Results 56424 1Craneware Announces Fiscal Year End Results 56424 2Craneware Announces Fiscal Year End Results 56424 3Invision Sally Jobe Names Breast Network Medical Director 56421 1Invision Sally Jobe Names Breast Network Medical Director 56421 2Cancer Drug May Fight Alzheimers 56418 1
...for Sept. 29, LA JOLLA, Calif., June 30 TorreyPi...nced that data presented at the 50th Annual,Scient...ed that, in,addition to meeting the primary endpoi...ny,s lead AMPA/kainate-type glutamate receptor ant...portant secondary endpoints in a,306-patient Phase...
...s Corporation (Nasdaq: UTHR ) and its wholly-owne...bmission of a New Drug Application,(NDA) to the U....g approval,of an inhaled formulation of treprostin...hypertension (PAH), a chronic, life-threatening di...g which the FDA will examine the,application for c...
Other Medicine Technology:Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 2Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 3New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 2New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 3New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 4
MYO-VAD™ Cardiac Assist Device
LOGIQ Book XP
Rio™ Aspiration Catheter
VASOVIEW® HemoPro™ Endoscopic Vessel Harvesting System
Medicine Products: